USTR 301 report spells out big pharma’s Asian patent concerns

USTR 301 report spells out big pharma’s Asian patent concerns

The office of the United States Trade Representative has just released its annual 301 Special Report, a review of the state of intellectual property rights and their enforcement around the world. Although comprehensive in scope, the report makes…

Unlock unlimited access to all IAM content